Uploaded September 2026 | Updated November 2026, 2 days ago
This twice-a-year shot called lenacapavir could end the HIV epidemic—but supply is falling far short. Jon Cohen, a senior correspondent at Science, explains.
Learn more: https://scim.ag/3Vuch54
CREDITS: (FOOTAGE) SHANNON BRADLEY; (VIDEO PRODUCTION) K. MCLEAN/SCIENCE
#Health #Science #ScienceShorts
This twice-a-year shot called lenacapavir could end the HIV epidemic—but supply is falling far short. Jon Cohen, a senior correspondent at Science, explains.
Learn more: https://scim.ag/3Vuch54
CREDITS: (FOOTAGE) SHANNON BRADLEY; (VIDEO PRODUCTION) K. MCLEAN/SCIENCE
#Health #Science #ScienceShorts










